Multispecialty - Integro

Multispecialty

Status:

Enrolling

ClinicalTrials.gov:

NCT05900986

An Open-label, Single-arm, Phase 1b/2 Study to Investigate the Safety, Efficacy and Pharmacokinetics of LS301-IT in Female Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for Ductal Carcinoma in Situ (DCIS) or Stage I-II Primary Invasive Breast Cancer

Phase

Phase 1/2

Condition

Stage I-II primary invasive breast cancer